AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Immutac 0.1% Ointment

Prescription Icon
Prescription Required

Marketer

Bills Biotech Pvt. Ltd.

Salt Composition

Tacrolimus (0.1% w/w)

Overview Immutac 0.1% Ointment

Topical Immutac 0.1% ointment effectively manages eczema (atopic dermatitis) by modulating the inflammatory response of specific immune cells responsible for skin redness and swelling. This reduces itching and improves the appearance of atopic dermatitis lesions. Apply Immutac 0.1% ointment externally, 2-4 times daily to affected areas, or as directed by your physician. Gently and thoroughly rub the ointment into the skin. Avoid overuse and occlusive dressings. Seek medical advice if symptoms worsen or show no improvement after a fortnight. Common side effects may include skin redness (erythema), headache, folliculitis, and localized reactions such as burning, irritation, itching, or redness at the application site. Use during pregnancy or breastfeeding is generally discouraged unless deemed essential by your doctor.

Primary Ingredients of Immutac 0.1% Ointment

The information is unavailable.

Uses of Immutac 0.1% Ointment

Managing atopic eczema

Major Benefits of Immutac 0.1% Ointment:

Apply this medication topically only. Follow your physician's instructions regarding dosage and treatment length. Always consult the product label for application guidelines prior to use. Ensure the affected skin is clean and dry before gently rubbing in the cream.

Common Side effects of Immutac 0.1% Ointment:

  • Application site reactions (burning, irritation, itching and redness)
  • Headache
  • Hair follicle inflammation

How to use Immutac 0.1% Ointment:

Apply this medication only to the skin's surface. Follow your physician's instructions regarding dosage and treatment length. Always consult the product label for application guidelines. Ensure the affected area is clean and dry before gently rubbing in the cream.

How Immutac 0.1% Ointment works:

Dermacalm 0.1% ointment, an immunosuppressant topical medication, reduces skin inflammation by inhibiting the action of immune cells responsible for redness and swelling. This alleviates itching and enhances the appearance of rashes associated with atopic dermatitis.

SAFETY ADVICE

AlcoholAlcoholNone

No known drug interactions.

PregnancyPregnancyCONSULT YOUR DOCTOR

Topical Immutac 0.1% application might pose risks during gestation. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible hazards prior to any prescription. Seek medical advice.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Application of Immutac 0.1% Ointment while breastfeeding is likely safe. Available data from human studies indicates minimal risk to the infant.

DrivingDrivingNone

No known drug interactions.

KidneyKidneyNone

No known drug interactions.

LiverLiverNone

No known drug interactions.

What if you forget to take Immutac 0.1% Ointment :

Should you forget a dose of Immutac 0.1% Ointment, apply it immediately. If, however, your next scheduled application is imminent, omit the missed dose and resume your usual treatment regimen.

Facts to Know About Immutac 0.1% Ointment

LabelValue
Type of Compound Large-ring lactone antibiotics
Potential for Dependence None.
Type of Medication Cancer-fighting drugs
Mechanism of Action Drugs suppressing the immune system: Calcineurin inhibitor class.

FAQs on Immutac 0.1% Ointment

Pimecrolimus 0.1% ointment is an immunomodulatory medication that primarily reduces immune system activity. This topical treatment is indicated for adults with moderate to severe atopic dermatitis unresponsive to, or experiencing adverse effects from, corticosteroids. Atopic dermatitis involves an overactive skin immune response, resulting in inflamed, itchy, and dry skin. Pimecrolimus 0.1% ointment modifies this aberrant immune response, thus alleviating skin inflammation and pruritus.
Topical application of Immutac 0.1% Ointment can induce localized skin reactions. These may include mild to moderate irritation, burning, and itching, typically resolving within a week. Redness, warmth, pain, altered sensation, and rash are also frequently observed. Treatment with this ointment elevates the patient's susceptibility to folliculitis, herpes simplex, acne, and cold sores.
Immutac 0.1% Ointment offers a safe and effective short-term topical treatment for atopic dermatitis, demonstrating superior safety compared to other immunosuppressant medications. Its minimal systemic absorption following cutaneous application results in fewer adverse effects than oral immunosuppressants.
Immutac 0.1% Ointment is not a controlled substance and poses no risk of misuse. The designation of a substance as "controlled" reflects its potential for abuse, requiring authorization from both medical professionals and regulatory bodies for dispensing.
Prolonged application of Immutac 0.1% Ointment is associated with a heightened lymphoma risk (a type of lymph node tumor). Limited research indicates a link between Immutac 0.1% Ointment, or comparable treatments, and the development of skin cancer or lymphoma in a small number of patients. Seek medical advice if Immutac 0.1% Ointment use exceeds six weeks, or if your eczema symptoms fail to improve or worsen during treatment.
Immutac 0.1% Ointment is non-steroidal. This medication modifies immune system function and treats eczema, particularly atopic dermatitis. A key benefit is the absence of skin thinning (atrophy) or other adverse effects associated with steroids.
Immutac 0.1% Ointment
271
MRP 330
17% off